HCA Healthcare (NYSE:HCA) reported second-quarter earnings that beat expectations, prompting the hospital operator to raise its full-year guidance.
Adjusted EPS came in at $6.84, topping estimates by $0.57, while revenue reached $18.61 billion, exceeding the $18.49 billion consensus.
Same-facility admissions rose 1.8%, and equivalent admissions increased 1.7% year-over-year. Emergency room visits rose 1.3%, while inpatient and outpatient surgeries dipped 0.3% and 0.6%, respectively. Revenue per equivalent admission grew 4.0% from the prior year.
HCA now expects 2025 revenue between $74.0 billion and $76.0 billion, up from its earlier range of $72.8 billion to $75.8 billion. Adjusted EBITDA is forecast at $14.7 billion to $15.3 billion, and diluted EPS is projected at $25.50 to $27.00, up from the previous $24.05 to $25.85 range.
